Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Intra-ovarian Infusion in Perimenopausal Women
NCT03951194Phase 3Recruiting
- Sponsor
- Genesis Athens Clinic
- Start
- Jun 2019
- Primary completion
- Jan 2027
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of autologous platelet rich plasma gel + autologous platelet rich plasma injection in perimenopause, infertility and Menstrual Disorder (2 arms), sponsored by Genesis Athens Clinic. Primary endpoints: Restoration of menstrual cycle regularity at 3 months and Serum Follicle Stimulating Hormone levels at 3 months. Started Jun 2019; status: recruiting.
02
Drugs
autologous platelet rich plasma gel + autologous platelet rich plasma injection
03
Conditions
perimenopauseinfertilityMenstrual Disorder
Beyond the preview
Go deeper on NCT03951194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03951194.